Tatsuhiro Ishida

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Acute Myeloid Leukemia

Human Serum Albumin

Top Venues

Molecular pharmaceutics

Pharmaceuticals (Basel, Switzerland)

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Sherif A Gaballa, Taro Shimizu, Haruka Takata, Hidenori Ando, Mohamed Ibrahim, Sherif E Emam, Nana Cristina Amorim Matsuo, Yuri Kim, Youssef W Naguib, Fatma M Mady, Khaled A Khaled, Tatsuhiro Ishida
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular pharmaceutics 21 (2) (2024)
Mayumi Ikeda-Imafuku, Tatsuya Fukuta, Victor Tuan Giam Chuang, Tomohiro Sawa, Toru Maruyama, Masaki Otagiri, Tatsuhiro Ishida, Yu Ishima
Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Mayumi Ikeda-Imafuku, Tatsuya Fukuta, Victor Tuan Giam Chuang, Tomohiro Sawa, Toru Maruyama, Masaki Otagiri, Tatsuhiro Ishida, Yu Ishima
Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Sherif A Gaballa, Taro Shimizu, Haruka Takata, Hidenori Ando, Mohamed Ibrahim, Sherif E Emam, Nana Cristina Amorim Matsuo, Yuri Kim, Youssef W Naguib, Fatma M Mady, Khaled A Khaled, Tatsuhiro Ishida
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular pharmaceutics 21 (2) (2024)
Mayumi Ikeda-Imafuku, Tatsuya Fukuta, Victor Tuan Giam Chuang, Tomohiro Sawa, Toru Maruyama, Masaki Otagiri, Tatsuhiro Ishida, Yu Ishima
Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Sherif A Gaballa, Taro Shimizu, Haruka Takata, Hidenori Ando, Mohamed Ibrahim, Sherif E Emam, Nana Cristina Amorim Matsuo, Yuri Kim, Youssef W Naguib, Fatma M Mady, Khaled A Khaled, Tatsuhiro Ishida
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular pharmaceutics (2024)
Kengo Yasuda, Hitoshi Maeda, Ryo Kinoshita, Yuki Minayoshi, Yuki Mizuta, Yuka Nakamura, Shuhei Imoto, Koji Nishi, Keishi Yamasaki, Mina Sakuragi, Teruya Nakamura, Mayumi Ikeda-Imafuku, Yasunori Iwao, Yu Ishima, Tatsuhiro Ishida, Yasuko Iwakiri, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama
Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticles for the Treatment of Hepatitis. ACS nano (2023)
Hiromi Sakai, Tomoko Kure, Naoko Kobayashi, Tadashi Ito, Yasushi Yamada, Tetsuya Yamada, Rina Miyamoto, Takahito Imaizumi, Jiro Ando, Takaomi Soga, Yasuo Osanai, Makoto Ogawa, Taro Shimizu, Tatsuhiro Ishida, Hiroshi Azuma
Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents. ACS omega 9 (1) (2023)
Hiromi Sakai, Tomoko Kure, Naoko Kobayashi, Tadashi Ito, Yasushi Yamada, Tetsuya Yamada, Rina Miyamoto, Takahito Imaizumi, Jiro Ando, Takaomi Soga, Yasuo Osanai, Makoto Ogawa, Taro Shimizu, Tatsuhiro Ishida, Hiroshi Azuma
Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents. ACS omega 9 (1) (2023)
Hiroshi Azuma, Toraji Amano, Naoya Kamiyama, Naofumi Takehara, Maki Jingu, Harumi Takagi, Osamu Sugita, Naoko Kobayashi, Tomoko Kure, Taro Shimizu, Tatsuhiro Ishida, Masanori Matsumoto, Hiromi Sakai
First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative. Blood advances 6 (21) (2022)
Naoki Hirakawa, Yu Ishima, Ryo Kinoshita, Ryuto Nakano, Victor Tuan Giam Chuang, Hidenori Ando, Taro Shimizu, Keiichiro Okuhira, Toru Maruyama, Masaki Otagiri, Tatsuhiro Ishida
Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice. ACS applied bio materials 4 (5) (2021)
Maichi Hama, Yu Ishima, Victor Tuan Giam Chuang, Hidenori Ando, Taro Shimizu, Tatsuhiro Ishida
Evidence for Delivery of Abraxane via a Denatured-Albumin Transport System. ACS applied materials & interfaces 13 (17) (2021)
Hidenori Ando, Yuta Murakami, Kiyoshi Eshima, Tatsuhiro Ishida
A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML). Cancer reports (Hoboken, N.J.) (2021)
Nehal E Elsadek, Eri Hondo, Taro Shimizu, Haruka Takata, Amr S Abu Lila, Sherif E Emam, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida
Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice. Molecular pharmaceutics 17 (8) (2020)
Hidenori Ando, Masakazu Fukushima, Kiyoshi Eshima, Taichi Hasui, Taro Shimizu, Yu Ishima, Cheng-Long Huang, Hiromi Wada, Tatsuhiro Ishida
A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model. Cancer medicine 8 (17) (2019)
Taro Shimizu, Amr Selim Abu Lila, Yoshino Kawaguchi, Yuna Shimazaki, Yuki Watanabe, Yu Mima, Yosuke Hashimoto, Keiichiro Okuhira, Gert Storm, Yu Ishima, Tatsuhiro Ishida
A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes. Journal of immunology (Baltimore, Md. : 1950) 201 (10) (2018)
Hidenori Ando, Amr S Abu Lila, Masao Tanaka, Yusuke Doi, Yasuko Terada, Naoto Yagi, Taro Shimizu, Keiichiro Okuhira, Yu Ishima, Tatsuhiro Ishida
Intratumoral Visualization of Oxaliplatin within a Liposomal Formulation Using X-ray Fluorescence Spectrometry. Molecular pharmaceutics 15 (2) (2018)
Taro Shimizu, Amr S Abu Lila, Miho Nishio, Yusuke Doi, Hidenori Ando, Masami Ukawa, Yu Ishima, Tatsuhiro Ishida
Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model. Cancer science 108 (9) (2017)